Currently Viewing:
ISPOR 2018
Dr Harlan Krumholz on Barriers Preventing Healthcare From Using Data to Improve Care
August 01, 2018
Dr Clifford Goodman Discusses How Healthcare Should Address Social Determinants of Health
July 20, 2018
Currently Reading
Sally Okun on How Informed Patients Feel When Starting Treatment After a New Diagnosis
July 09, 2018
Dr Adrian F. Hernandez: Mapping Human Health Through Project Baseline
July 03, 2018
Dr Harlan Krumholz: How Healthcare Can Better Implement New Technologies
June 29, 2018
Dr Ejim Mark: Challenges With and Protecting the Increasing Amount of Health Data
June 27, 2018
Sally Okun Outlines What Patients Define as Good Care
June 26, 2018
Dr Adrian F. Hernandez on the Future of Real-World Evidence
June 20, 2018
Dr Harlan Krumholz on Using New Technologies, Data Generation to Prevent or Address Epidemics
June 18, 2018
Sally Okun: Using Digital Health Improvements to Include the Patient Voice in Healthcare
June 14, 2018
Valuation Challenges and Ethical Implications of Cures
May 23, 2018
Value Assessments in the Age of Personalized Medicine May Require a Cultural Shift, Panel Says
May 23, 2018
Dr Ejim Mark: Digital Health Runs the Risk of Exacerbating Disparities
May 23, 2018
Dr Steven Pearson Highlights the Challenge of Evaluating New Interventions That Cure Diseases
May 23, 2018
Panelists Give Payer, Patient, and Economist Perspectives on High-Cost Drugs for Rare Diseases
May 23, 2018
Dr Adrian Hernandez Highlights the Use of Real-World Evidence and Current Barriers
May 22, 2018
Personalizing the Digital Data Revolution in Healthcare
May 22, 2018
All-Cause Healthcare Payments Substantial for Younger Adults With Depression, and Other Poster Findings at ISPOR
May 22, 2018
Dr Clifford Goodman Discusses the Challenge of Valuing New, Expensive Therapies for Rare Diseases
May 22, 2018

Sally Okun on How Informed Patients Feel When Starting Treatment After a New Diagnosis

The most common question patients ask when they start a new treatment after a new diagnosis is "what will this do to me?" explained Sally Okun, RN, MMHS, vice president, Policy and Ethics, PatientsLikeMe.


This page contains sponsored advertising.

The most common question patients ask when they start a new treatment after a new diagnosis is "what will this do to me?" explained Sally Okun, RN, MMHS, vice president, Policy and Ethics, PatientsLikeMe.

Transcript

How well-informed do patients usually feel when they start treatment after a new diagnosis?

I’m not so sure I can point to any 1 data point that would say, “well, this is how well informed they are.” What I would say is that over the course of the last number of years, as we’ve created a framework for what we call, “the patient and caregiver journey,” we’ve identified different points in time across that journey and the kinds of questions that patients have and the things that they are experiencing during those different stages. And so, we have again distilled that down to about 6 common questions that most anybody has. Regardless of what their condition is, they seem to pretty much all fall around the same 6 questions, and 1 of them that I thought was interesting, in light of your question, was that, “what will this treatment do to me?”, or, “what will this diagnosis do to me?”, or, “what will this prescription drug that you’re going to prescribe for me do to me?”

 So, I think what we’re finding is that when patients come into an environment like PatientsLikeMe and tell us about that journey they’ve been on, what we’ve learned is that they didn’t have a good understanding in the beginning, and these are the kinds of questions that they needed to ask, and they didn’t necessarily get the answers that they needed. So, when they come into an environment like ours and they start asking other patients, they’re starting to get some information that they wouldn’t previously have gotten maybe from the clinician. It’s not that the clinician isn’t giving it to them; they might be giving it to them in a form that isn’t necessarily digestible for the patient. It’s not as easily understood as another person telling them about what that treatment had done for them and not necessarily saying, “it’s going to do the same for you, but these are the things that I experienced.”

You’re question made me pause, and I almost asked you not to ask me because I didn’t have a data point I could point to, but I think the interviews that we do continuously reinforce that patients have many, many, many questions, and they often are the kinds of things that don’t necessarily get addressed, but that one question of, “what will this do to me?” is, I think, what gets the closest to what you’re asking. And so, it’s 1 of our 6 common questions that all patients ask, regardless, again, of the conditions they have, and they don’t necessarily get it answered all the time. 

 
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up
×

Sign In

Not a member? Sign up now!